Nonprofit · EIN 20-1945347
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION
Tax-exempt · QUINCY, MA 02171
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $8,684,021 | $4,788,567 | $3,895,454 | $27,566,655 | $5,093,388 | $22,473,267 |
| December 31, 2024 | 990 | $3,993,657 | $3,778,477 | $215,180 | $21,377,613 | $4,541,212 | $16,836,401 |
| December 31, 2023 | 990 | $3,196,257 | $3,580,473 | -$384,216 | $20,633,243 | $5,100,489 | $15,532,754 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $7,880,794
- Program service revenue
- $0
- Investment income
- $785,476
- Net gain from sales of assets
- $184,556
- Other revenue
- $17,751
Expenses
- Grants and similar amounts paid
- $2,989,009
- Compensation of officers, directors and key employees
- $212,863
- Other salaries and wages
- $728,878
- Salaries, compensation and benefits (total)
- $1,047,283
- Professional fundraising fees
- $54,671
- Accounting fees
- $66,119
- Occupancy
- $54,510
- Travel
- $19,509
- Program services (functional)
- $3,955,548
- Management and general (functional)
- $276,011
- Fundraising (functional)
- $557,008
Balance sheet and other
- Total assets, start of year
- $21,377,613
- Total assets, end of year
- $27,566,655
- Total liabilities, end of year
- $5,093,388
- Net assets, end of year
- $22,473,267
- Publicly traded securities
- $23,731,261
- Net assets without donor restrictions
- $5,277,500
- Net assets with donor restrictions
- $17,195,767
- Gross receipts
- $9,009,925
- Employees
- 7
- Volunteers
- 14
- Year formed
- 2004
- State of legal domicile
- MA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ELYSE GELLERMAN | CHIEF EXECUTIVE OFFICER Officer | 40 | $212,863 | $0 |
| SUSAN HARRINGTON | CHIEF DEVELOPMENT OFFICER Highest-paid employee | 40 | $198,757 | $1,488 |
| JESSICA THOMAS | DIRECTOR OF PATIENT EDUCATION Highest-paid employee | 40 | $122,539 | $34,273 |
| ANNA GREENE | DIRECTOR OF RESEARCH Highest-paid employee | 40 | $154,781 | $0 |
| MARK LEWIS MD UNTIL 032025 | DIRECTOR Trustee or director | 4 | $0 | $0 |
| VALORIE SEYFERT AS OF 492025 | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JULIE SHAFFER MEBANE | VICE PRESIDENT Trustee or director, Officer | 4 | $0 | $0 |
| LAURIE RAINS | DIRECTOR Trustee or director | 4 | $0 | $0 |
| ANTHONY DETRE | DIRECTOR Trustee or director | 4 | $0 | $0 |
| ELAINE NORD AS OF 492025 | DIRECTOR Trustee or director | 4 | $0 | $0 |
| STEPHEN KAUFER | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JOSH MAILMAN | TREASURER Trustee or director, Officer | 4 | $0 | $0 |
| JOSEPH LI MD | DIRECTOR Trustee or director | 4 | $0 | $0 |
| TODD GILMAN | PRESIDENT Trustee or director, Officer | 4 | $0 | $0 |
| SUZANNE LUDLOW | SECRETARY Trustee or director, Officer | 4 | $0 | $0 |
2 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| LAURIE LITTLEPAGE | DIRECTOR Trustee or director | 4 | $0 |
| CARRIE CAMINO | DIRECTOR Trustee or director | 4 | $0 |
990 for the year ended December 31, 2024: 19 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ELYSE GELLERMAN | CHIEF EXECUTIVE OFFICER Officer | 40 | $199,006 | $0 |
| SUSAN HARRINGTON | CHIEF DEVELOPMENT OFFICER Highest-paid employee | 40 | $179,000 | $491 |
| ANNA GREENE | DIRECTOR OF RESEARCH Highest-paid employee | 40 | $137,064 | $0 |
| JESSICA THOMAS | DIRECTOR OF PATIENT EDUCATION Highest-paid employee | 40 | $112,109 | $20,162 |
| CHRISTINA COFFEY UNTIL 072024 | DIRECTOR OF COMMUNICATIONS Highest-paid employee | 1 | $107,547 | $5,017 |
| MARK LEWIS MD | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JONATHAN SOROFF UNTIL 012024 | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JULIE SHAFFER MEBANE | VICE PRESIDENT Trustee or director, Officer | 4 | $0 | $0 |
| LAURIE RAINS | DIRECTOR Trustee or director | 4 | $0 | $0 |
| ANTHONY DETRE | DIRECTOR Trustee or director | 4 | $0 | $0 |
| STEPHEN BLACKWOOD PHD | DIRECTOR Trustee or director | 4 | $0 | $0 |
| STEPHEN KAUFER | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JOSH MAILMAN | TREASURER Trustee or director, Officer | 4 | $0 | $0 |
| JOSEPH LI MD | DIRECTOR Trustee or director | 4 | $0 | $0 |
| BRENDAN FOLEY UNTIL 62024 | SECRETARY Trustee or director, Officer | 4 | $0 | $0 |
| TODD GILMAN | PRESIDENT Trustee or director, Officer | 4 | $0 | $0 |
| SUZANNE LUDLOW | SECRETARY Trustee or director, Officer | 4 | $0 | $0 |
| LAURIE LITTLEPAGE | DIRECTOR Trustee or director | 4 | $0 | $0 |
| CARRIE CAMINO AS OF 42024 | DIRECTOR Trustee or director | 4 | $0 | $0 |
990 for the year ended December 31, 2023: 16 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| ELYSE GELLERMAN | CHIEF EXECUTIVE OFFICER Officer | 40 | $197,381 | $0 |
| SUSAN HARRINGTON | CHIEF DEVELOPMENT OFFICER Highest-paid employee | 40 | $159,003 | $491 |
| CHRISTINE COFFEY | DIRECTOR OF COMMUNICATIONS Highest-paid employee | 40 | $135,321 | $8,601 |
| MARK LEWIS MD | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JONATHAN SOROFF | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JULIE SHAFFER MEBANE | VICE PRESIDENT Trustee or director, Officer | 4 | $0 | $0 |
| LAURIE RAINS | DIRECTOR Trustee or director | 4 | $0 | $0 |
| ANTHONY DETRE | DIRECTOR Trustee or director | 4 | $0 | $0 |
| STEPHEN BLACKWOOD | DIRECTOR Trustee or director | 4 | $0 | $0 |
| STEPHEN KAUFER | DIRECTOR Trustee or director | 4 | $0 | $0 |
| JOSH MAILMAN | TREASURER Trustee or director, Officer | 4 | $0 | $0 |
| JOSEPH LI MD | DIRECTOR Trustee or director | 4 | $0 | $0 |
| BRENDAN FOLEY | SECRETARY Trustee or director, Officer | 4 | $0 | $0 |
| TODD GILMAN | PRESIDENT Trustee or director, Officer | 4 | $0 | $0 |
| SUZANNE LUDLOW | DIRECTOR Trustee or director | 4 | $0 | $0 |
| LAURIE LITTLEPAGE | DIRECTOR Trustee or director | 4 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 100 HANCOCK ST THIRD FLOOR, QUINCY, MA 02171-1794
- In care of
- % RONALD HOLLANDER
- Principal officer (990 for 2025)
- ELYSE GELLERMAN, 100 HANCOCK ST THIRD FLOOR, QUINCY, MA 02171
- Signed the 990
- ELYSE GELLERMAN, CHIEF EXECUTIVE OFFICER
- Phone
- (617) 946-1780
- Website
- NETRF.ORG
- Return prepared by
- POZERSKI HATCH & COMPANY
Mission
TO FUND RESEARCH TO DISCOVER CURES AND MORE EFFECTIVE TREATMENTS FOR NEUROENDOCRINE CANCERS. THE NETRF IS COMMITTED TO IMPROVING THE LIVES OF THOSE AFFECTED BY NEUROENDOCRINE CANCER BY PROVIDING INFORMATION & EDUCATIONAL RESOURCES.
Program accomplishments
- THE NEUROENDOCRINE TUMOR RESEARCH FOUNDATION FUNDS SCIENTIFIC RESEARCH AROUND THE WORLD TO DISCOVER THE CAUSES, IMPROVE TREATMENTS, AND FIND CURES FOR NEUROENDOCRINE CANCER.Expenses $3,467,199 · grants $2,989,009 · revenue $17,751
- NETRF PROVIDES EDUCATION AND SUPPORT FOR PEOPLE WITH NEUROENDOCRINE CANCER AND THEIR FAMILIES. THROUGH EDUCATIONAL CONFERENCES, A PATIENT GUIDE, PODCASTS AND A COMPREHENSIVE WEBSITE, NETRF HELPS PATIENTS UNDERSTAND THEIR DIAGNOSIS AND TREATMENT OPTIONS.Expenses $404,871
- NETRF CONDUCTS OUTREACH TO OTHER NET-RELATED ORGANIZATIONS IN THE UNITED STATES AND BEYOND TO CONVENE RESEARCHERS AND FACILITATE SCIENTIFIC COLLABORATION. THROUGH ITS WORK AND LEADERSHIP WITH THESE OTHER GROUPS, NETRF ADVANCES UNDERSTANDING OF NEUROENDOCRINE TUMORS AND THE NEEDS OF NET PATIENTS. NETRF ALSO WORKS WITH PATIENT SUPPORT GROUPS TO CONNECT TO THE LARGER NET COMMUNITY.Expenses $83,478
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-1945347
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2005
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G123)
- Assets (IRS master file)
- $27,566,655
- Income (IRS master file)
- $9,009,925
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $8,684,021 | $4,788,567 | $27,566,655 | IRS |
| 990 | December 2024 | $3,993,657 | $3,778,477 | $21,377,613 | IRS |
| 990 | December 2023 | $3,196,257 | $3,580,473 | $20,633,243 | XML |
| 990 | December 2022 | $3,075,371 | $3,490,037 | $20,523,118 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-1945347).
Questions about NEUROENDOCRINE TUMOR RESEARCH FOUNDATION
- What is the EIN of NEUROENDOCRINE TUMOR RESEARCH FOUNDATION?
- The employer identification number (EIN) of NEUROENDOCRINE TUMOR RESEARCH FOUNDATION is 20-1945347.
- Is NEUROENDOCRINE TUMOR RESEARCH FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2005.
- Are donations to NEUROENDOCRINE TUMOR RESEARCH FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does NEUROENDOCRINE TUMOR RESEARCH FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of NEUROENDOCRINE TUMOR RESEARCH FOUNDATION due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did NEUROENDOCRINE TUMOR RESEARCH FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of NEUROENDOCRINE TUMOR RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2025 names ELYSE GELLERMAN.
- Who are the officers and directors of NEUROENDOCRINE TUMOR RESEARCH FOUNDATION?
- The 990 for the year ended December 31, 2025 lists 17 people; 4 received compensation from the organization, the highest $212,863 (ELYSE GELLERMAN, CHIEF EXECUTIVE OFFICER).
- How much revenue does NEUROENDOCRINE TUMOR RESEARCH FOUNDATION have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $8,684,021, expenses of $4,788,567 and total assets of $27,566,655 at year end.
Other nonprofits in QUINCY
- PROSTATE HEALTH EDUCATION NETWORK INC EIN 33-1042404 · last filed 990 for 2025
- NORTHROP GRUMMAN VEBA MASTER TRUST I EIN 95-3386394 · last filed 990 for 2024
- NEIGHBORHOOD HOUSING SERVICES OF THE SOUTH SHORE INC EIN 04-2732439 · last filed 990 for 2025
- NATIONAL FIRE PROTECTION ASSOCIATION EIN 04-1653090 · last filed 990 for 2025
- QUINCY COMMUNITY ACTION PROGRAMS INC EIN 04-2391348 · last filed 990 for 2025
- MASSACHUSETTS TEACHERS ASSOCIATION EIN 04-1591200 · last filed 990 for 2025
- SOUTH SHORE YOUNG MENS CHRISTIAN ASSOCIATION EIN 04-2105881 · last filed 990 for 2025
- NELLIE MAE EDUCATION FOUNDATION INC EIN 04-2755323 · last filed 990 for 2024
All nonprofits in QUINCY · Massachusetts · Voluntary health associations and medical disciplines